Global Analgesics Market 2016-2020

#Snapshot img { margin: 10px !important; } Global analgesics market forecastAccording to the analgesics market statistics, the global analgesics market is envisaged to grow steadily and will post a CAGR of more than 4% over the forecast period. The advent of favorable regulatory norms and healthcare reforms around the world have encouraged the initiation and uptake of pain management programs to reduce the overall healthcare costs. For instance, the US Patient Protection and Affordable Care Act has provision for pain management. Such healthcare reforms have paved the way toward the development of effective analgesic medications. This recent increase in the introduction of favorable regulatory norms will lead to the augmented adoption of analgesics and will increase the analgesics market size in the coming years.The increasing use of off-label drugs is one of the significant trends spurring the growth prospects of this market over the forecast period. Off-label drugs are unapproved medications that are effective in treating diseases. Several off-label drugs, such as tricyclic antidepressants, selective serotonin reuptake inhibitors, antihistamines, anti-anxiety drugs, anticonvulsants, steroids, and analgesics are being increasingly used to manage the symptoms of pain. These drugs are prescribed with approved drugs as maintenance therapies. Moreover, since these drugs are less expensive than approved drugs, it will contribute to this market’s growth over the next four years.Segmentation by type and analysis of the analgesics market Prescription analgesicsOTC analgesicsThe prescription analgesics segment dominated the market and accounted for a market share of more than 52% over the forecast period. The growth of this market is attributed to the growing popularity of generics for pain management. Apart from their affordability, the rising number of individuals requiring analgesics and the widening distribution channels will propel the growth prospects for this segment by 2020.Geographical segmentation and analysis of the analgesics marketAmericasAPACEMEAIn terms of geography, the Americas led the global analgesics market and is anticipated to reach more than USD 18 billion by 2020. The rising prevalence of osteoarthritis is one of the most important drivers propelling this market’s growth in the Americas. Moreover, better access to healthcare services and various initiatives by the government to improve the healthcare infrastructure in the country will aid in the growth of this market in this region.Competitive landscape and key vendorsThe global analgesics market is highly fragmented owing to the presence of several small and large vendors. Due to the influx of new vendors, the level of competition is likely to intensify over the forecast period. Players in the market are constantly looking for ways to enhance their market presence by focusing on the implementation of various new business models and M&A activities.Key vendors in this market are PfizerBayer HealthCareSanofiEndoJohnson & JohnsonPurdue PharmaOther prominent vendors in the market are Achelios Therapeutics, Alder BioPharmaceuticals, Allergan, Amgen, AstraZeneca plc, Baxter, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, CoLucid Pharmaceuticals, Daiichi Sankyo Company, Dr. Reddy's Laboratories, DURECT Corporation, El Lilly & Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, GW Pharmaceuticals, Hospira, Immune Pharmaceuticals, Innovative Med Concepts LLC, Merck, NeurAxon, Novartis AG, OptiNose, Pain Therapeutics, RedHill, Sorrento Therapeutics, Suda, Taro Pharmaceuticals Industries, Teva Pharmaceuticals Industries, Tonix Pharmaceuticals Holding, Trigemina, UCB SA, Valeant Pharmaceuticals International, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.Key questions answered in the report includeWhat will the market size and the growth rate be in 2020?What are the key factors driving the global analgesics market?What are the key market trends impacting the growth of the global analgesics market?What are the challenges to market growth?Who are the key vendors in the global analgesics market?What are the market opportunities and threats faced by the vendors in the global analgesics market?What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?What are the key outcomes of the five forces analysis of the global analgesics market?Technavio also offers customization on reports based on specific client requirement.Related reports:Global Rheumatoid Arthritis Drugs Market 2016-2020Global Osteoarthritis Pain Drugs Market 2016-2020Global Pain Management Drugs Market 2016-2020

全球镇痛药市场预测根据镇痛药市场统计数据，全球镇痛药市场预计将稳步增长，并在预测期内实现超过4%的复合年增长率。全球范围内有利监管规范和医疗保健改革的涌现，鼓励了疼痛管理项目的启动和采纳，以降低整体医疗保健成本。例如，美国《患者保护与平价医疗法案》中就包含了疼痛管理的规定。此类医疗保健改革为有效镇痛药物的开发铺平了道路。近期有利于监管规范的引入将导致镇痛药采纳率的提升，并在未来几年内扩大镇痛药市场规模。标签外药物使用的日益增加是推动预测期内该市场增长前景的一个重要趋势。标签外药物是指未经批准但能有效治疗疾病的药物。多种标签外药物，如三环类抗抑郁药、选择性5-羟色胺再摄取抑制剂、抗组胺药、抗焦虑药、抗惊厥药、类固醇和镇痛药，正越来越多地被用于管理疼痛症状。这些药物与批准的药物一起作为维持疗法开具。此外，由于这些药物比批准的药物便宜，预计将在未来四年内推动该市场的增长。按类型划分的镇痛药市场细分及分析处方镇痛药OTC镇痛药处方镇痛药细分在市场中占据主导地位，并在预测期内占据了超过52%的市场份额。该市场的发展得益于用于疼痛管理的通用药物日益流行。除了其经济性外，需要镇痛药的个人数量不断增加以及分销渠道的扩大也将推动该细分市场到2020年的增长前景。地理细分及镇痛药市场分析美洲亚太地区中东及非洲从地理角度来看，美洲在全球镇痛药市场中占据领先地位，预计到2020年将超过180亿美元。骨关节炎发病率的上升是该市场在美洲增长的最重要驱动力之一。此外，该地区医疗保健服务的改善以及政府为改善国家医疗保健基础设施而采取的各项举措，将有助于该地区市场的增长。竞争格局及主要供应商由于众多小型和大型供应商的存在，全球镇痛药市场高度分散。由于新供应商的涌入，预计在预测期内竞争程度将加剧。市场上的参与者不断寻求通过实施各种新的商业模式和并购活动来增强其市场地位。该市场的主要供应商包括辉瑞、拜耳健康护理、赛诺菲、恩度、强生、普强制药公司、阿斯利康、百时美施贵宝公司、科卢西德制药公司、大日本制药公司、雷迪博士实验室、DURECT公司、艾利·利利公司、F. 霍夫曼-拉罗什公司、葛兰素史克公司、加文制药公司、 Hospira、免疫制药公司、创新医疗概念公司、默克公司、NeurAxon、诺华公司、OptiNose、疼痛治疗公司、雷德希尔、索伦托制药公司、苏达、达仁药物工业公司、特瓦制药工业公司、Tonix制药公司、Trigemina、UCB SA、Valeant制药公司国际、WEX制药公司和Zynerba制药公司。本报告回答的关键问题包括：2020年市场规模和增长率将如何？推动全球镇痛药市场的关键因素是什么？影响全球镇痛药市场增长的关键趋势是什么？市场增长面临的挑战有哪些？全球镇痛药市场的主要供应商是谁？全球镇痛药市场的供应商面临的市场机遇和威胁有哪些？影响美洲、亚太地区和中东及非洲市场份额的趋势因素是什么？全球镇痛药市场五力分析的关键结果是什么？Technavio还根据特定客户需求对报告进行定制。相关报告：全球类风湿性关节炎药物市场2016-2020全球骨关节炎疼痛药物市场2016-2020全球疼痛管理药物市场2016-2020